
|Articles|January 1, 2003
Accutane Illicitly Sold, Congress, FDA Warn
Author(s)Thomas P. Skernivitz
Washington - Tighter restrictions on Accutane could have a reverse effect - increased black market activity - the FDA told a congressional investigative subcommittee on Dec. 11.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
3
Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older
4
Introducing Dermatology Times NP/PA Connect
5











